Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients

Confirmation of CD19+ B-Lymphocyte Depletion Prior to Intake of the Second Dose of Ocrelizumab in Multiple Sclerosis Patients

The aim of the retrospective study was to compare the immunophenotyping of T-lymphocytes, B-lymphocytes, and natural killer cells before the administration of the first and the second dose of ocrelizumab in 22 patients with multiple sclerosis in a three-year period (2019–2021) at the Department of N...

Full description

Bibliographic Details
Main Authors: Marija Radmilo, Sanda Pavelin, Igor Vujović, Joško Šoda, Maja Rogić Vidaković
Format: Article
Language:English
Published: MDPI AG 2023-01-01
Series:Biomedicines
Subjects:
multiple sclerosis
ocrelizumab
immunophenotyping
B-lymphocytes
T-lymphocytes
NK cells
Online Access:https://www.mdpi.com/2227-9059/11/2/353

Similar Items

Similar Items